Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „Overall“
Suchtreffer
Begriffe & Kennungen
Clopidogrel Krka · 4.8 · In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both gro
Eintrag öffnenClopidogrel TAD · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel TAD · 4.8 · In CLARITY, there was an overall increase in bleeding in the clopidogrel plus ASA group vs. the placebo plus A
Eintrag öffnenClopidogrel TAD · 4.8 · In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both gro
Eintrag öffnenClopidogrel Taw Pharma (previously Clopidogrel Mylan) · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel Taw Pharma (previously Clopidogrel Mylan) · 4.8 · In CLARITY, there was an overall increase in bleeding in the clopidogrel plus ASA group vs. the placebo plus A
Eintrag öffnenClopidogrel Taw Pharma (previously Clopidogrel Mylan) · 4.8 · In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both gro
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · 9 In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both g
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · In CLARITY, there was an overall increase in bleeding in the clopidogrel plus ASA group vs. the placebo plus A
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.8 · 9 In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both g
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.8 · In CLARITY, there was an overall increase in bleeding in the clopidogrel plus ASA group vs. the placebo plus A
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.8 · In CLARITY, there was an overall increase in bleeding in the clopidogrel plus ASA group vs. the placebo plus A
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.8 · In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both gro
Eintrag öffnenClopidogrel ratiopharm · 4.8 · 9 In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both g
Eintrag öffnenClopidogrel ratiopharm · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel ratiopharm · 4.8 · In CLARITY, there was an overall increase in bleeding in the clopidogrel plus ASA group vs. the placebo plus A
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnen